This page aims to give you an overview of the European types of funding most suitable for your discipline in relation to the Innovation Axis.
Horizon 2020 offers 3 programmes for basic research in Medicine & Pharmaceutics: Future and Emerging Technologies (FETs), and the grants of the European Research Council (ERC), aiming at excellence, and the Marie Sklodowska Curie Actions (MSCA), promoting mobility.
Researchers in Medicine & Pharmaceutics will find topics in two Societal Challenges: "Health, demographic change and wellbeing" and "Food security, sustainable agriculture, marine and maritime research and the bio-economy", as well as in the European and Developing Countries Clinical Trials Partnership (EDCTP) and Ambient Assisted Living (AAL).
Health, demographic change and wellbeing
Food security, sustainable agriculture, marine and maritime research and the bio-economy
European and Developing Countries Clinical Trials Partnership (EDCTP)
Ambient Assisted Living (AAL)
There are a large number of interesting topics in the Industrial Leadership pillar under "Leadership in Enabling & Industrial Technologies", specifically in the Key Enabling Technologies (KETs) in the area of Biotechnology. Funding possibilities also exist in the Public Private Partnerships (PPPs) and in the Innovative Medicines Initiative (IMI), a Joint Technology Initiative (JTI). In addition, a specific area is reserved for SME bottom-up topics.
Facilitating cooperation activities in research and innovation is the key to bridging the gap between research and the market. Partners for various types of cooperation are available in the Enterprise Europe Network (EEN) database. Below are a selection of partnering profiles related to this thematic. Further cooperation opportunities are published on the EEN Marketplace.